DUPIXENT® (dupilumab) injection
DUPIXENT is indicated for the treatment of adult and pediatric patients aged 6 months and older with moderate-to-severe atopic dermatitis (AD) whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.
EMGALITY (galcanezumab-gnlm) injection
EMGALITY (galcanezumab-gnlm) injection is a humanized IgG4 monoclonal antibody specific for calcitonin-gene related peptide (CGRP) ligand. EMGALITY is indicated for the preventive treatment of migraine in adults.
DIOFULVIN TABLETS® (Griseofulvin® tablets 500mg)
Diofulvin is a fungistatic antibiotic that exert its effects by inhibiting fungal cell division through disruption of mitotic spindle structure. Each tab contains 500mg. Diofulvin is indicated for Dermatophyte, infection of the skin, scalp, hair and nails where topical therapy has failed or is inappropriate.

Contraception and the menstrual cycle
Contraception is the prevention of pregnancy by inhibiting sperm from reaching a mature ovum or by preventing a fertilized ovum from implanting in the endometrium.
Disease Vector control
Vectors are living organisms that serve as vehicles to transmit a pathogen (a disease-causing agent like a virus or parasite) from a host to a human or to an animal or both.
Differences between clinical death and biological death
Clinical death is defined as the period of respiratory, circulatory and brain arrest during which initiation of resuscitation can lead to recovery.
Key actors in the community health-care system
In most developing countries, the community health-care system represents at least five layers of care that respond to the comprehensive healthcare demands of its people
What is Medicinal chemistry and its evolution?
is that field of pharmaceutical sciences which applies the principles of chemistry and biology to the creation of knowledge leading to the introduction of new therapeutic agents

recombinant humanized IgG1

BYOOVIZ (ranibizumab-nuna) injection

January 17, 2023 January 17, 2023 / Age-Related Macular Degeneration, BYOOVIZ, Macular Edema, Myopic Choroidal Neovascularization, neovascularization, ocular angiogenesis, ranibizumab-nuna, recombinant humanized IgG1, Retinal Vein Occlusion, vascular occlusion, VEGF-A / Medicines / Leave a Comment

BYOOVIZ (ranibizumab-nuna) is a recombinant humanized IgG1 kappa isotype monoclonal antibody fragment designed for intraocular use. Ranibizumab-nuna binds to and inhibits the biologic activity of human vascular endothelial growth factor A (VEGF-A).

recombinant humanized IgG1

Cookies consent

Add gafacom.website to your Homescreen!